Medical specialists from United Kingdom tagged as investigators in clinical trials studying Neuroendocrine Tumors

Total 11 results

Andrew Moore, Dr
Seen in:
- Liverpool, Liverpool Royal Hospital
Trials:
- NCT04524442 (Principal Investigator)
Conditions:
- Gastroenteropancreatic Neuroendocrine Tumors
Daniel Krell
Seen in:
- London, Sarah Cannon Research Institute
Trials:
- NCT04579679 (Principal Investigator)
Conditions:
David Lau
Seen in:
- Surrey, Sutton, The Royal Marsden NHS Foundation Trust
Trials:
- NCT03840460 (Sub-Investigator)
Conditions:
- Pancreatic Adenocarcinoma
Lefteris Livieratos, PhD
Seen in:
- London, Guy's and St Thomas Hospitals Foundation Trust
Trials:
- NCT04922801 (Sub-Investigator)
Conditions:
Martin Weickert, Dr
Seen in:
- Coventry, University Hospitals Coventry & Warwickshire NHS Trust
Trials:
- NCT04524442 (Principal Investigator)
Conditions:
- Gastroenteropancreatic Neuroendocrine Tumors
Nicholas Reed
Seen in:
- Glasgow City, Glasgow, Gartnavel General Hospital
- Glasgow, The Beatson West of Scotland Cancer
Trials:
- NCT04211337 (Principal Investigator)
- NCT04524442 (Principal Investigator)
Conditions:
- Medullary Thyroid Cancer;
- Gastroenteropancreatic Neuroendocrine Tumors
Rohini Sharma, MD
Seen in:
- Greater London, London, Imperial College Healthcare NHS Trust
- London, Imperial College Healthcare NHS Trust
- London, Imperial College NHS Trust
Trials:
- NCT04362436 (Principal Investigator)
- NCT03682276 (Principal Investigator)
- NCT03397654 (Principal Investigator)
Conditions:
Tahani O Alkahtani, MSc
Seen in:
- London, Guy's and St Thomas Hospitals Foundation Trust
Trials:
- NCT04922801 (Sub-Investigator)
Conditions:
Tahir Shah, Dr
Seen in:
- Birmingham, University Hospitals Birmingham NHS Foundation Trust
Trials:
- NCT04524442 (Principal Investigator)
Conditions:
- Gastroenteropancreatic Neuroendocrine Tumors
Valerie Lewington, Professor
Seen in:
- London, Guy's and St Thomas Hospitals Foundation Trust
Trials:
- NCT04922801 (Principal Investigator)
Conditions:
Vineet Prakash, Dr
Seen in:
- Guildford, Royal Surrey County Hospital
Trials:
- NCT04524442 (Principal Investigator)
Conditions:
- Gastroenteropancreatic Neuroendocrine Tumors

Clinical Trials on Neuroendocrine Tumors

Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

Advanced Gastroenteropancreatic Neuroendocrine Tumor
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

Advanced Gastroenteropancreatic Neuroendocrine Tumor

China
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Recruiting

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Neuroendocrine Tumors,Gastroenteropancreatic

Taiwan
Amr Mohamed MD
Novatek Pharmaceuticals

Active, not recruiting

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

Neuroendocrine Carcinoma | Gastroenteropancreatic Neuroendocrine Tumor | Gastroenteropancreatic Neuroendocrine Neoplasm | Mixed Neuroendocrine-Non Neuroendocrine Neoplasm

United States
Francesco De Cobelli

Completed

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Pancreatic Neuroendocrine Tumor

Italy
Grupo Espanol de Tumores Neuroendocrinos

Active, not recruiting

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

Neuroendocrine Tumors | Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine Tumor

Spain
Australasian Gastro-Intestinal Trials Group

Completed

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study (CONTROL NETS)

Midgut Neuroendocrine Tumours | Pancreatic Neuroendocrine Tumours

Australia
TaiRx, Inc.

Active, not recruiting

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

Neuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor | Lung Neuroendocrine Neoplasm

Taiwan
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Neuroendocrine Tumors | Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors

United States
University Hospital, Basel, Switzerland
Swiss National Science Foundation; Paul Scherrer Institute (PSI)

Recruiting

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) (Beta plus)

Neuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Switzerland

Medical specialists from United Kingdom tagged as investigators in clinical trials studying Neuroendocrine Tumors

Clinical Trials on Neuroendocrine Tumors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations